Am I Doing Enough?

Am I Doing Enough?

By Pat Garcia-Gonzalez

Birthdays are a time to take stock on our life. This birthday, I feel unsettled, questioning if I am doing everything I can. A few weeks ago, I sat in a small consult room. A gentleman walked wearing gray slacks, a white buttoned shirt, and suit coat, he must have been in his 50’s. The doctor asked him a few questions and translated the answers for me. The man shared that he was the father of five children, he worked as a driver; earned $30 a month. He shared with the doctor that a few days before his medical appointment, he always starts feeling very anxious. I assumed this was related to finding out the status of his cancer, but he explained: “you see, doctor, when I come here to see you, I am taking bread out of my children’s mouth.” He went on to say with a matter-of-fact tone, that this was going to be the last time he came to the hospital for his cancer treatment.

Maybe it is this experience that stuck in my mind, or perhaps it is the proximity of my birthday that reminds me that my time to make a difference is finite. As I have matured in my role as CEO of The Max Foundation, I have come to understand that progress is gained through incremental steps, and I have come to accept small gains. I have great gratitude for the opportunity to help, and for those who make it possible. I am also grateful for having a voice in the current global oncology efforts to galvanize all stakeholders and strengthen the health systems in a systematic way. This is the long game, the results of which we will see in a too-far future for those who need help now.

The long game is important, but I worry that we might be veering off track and forgetting our responsibility to those who have cancer now and can’t wait. Helping those who need treatment now or building the future is not a binary choice. We can do both. Moreover, I know from experience that helping those who need help today is the fastest way to build the health system of the future. And it is the right thing to do. Today within just a six-month period, The Max Foundation and its 1,034 partners can have all systems in place to deliver an innovative cancer medicine at a national cancer hospital in a LMIC for the first time and start reaching patients in urgent need. The availability of medicine then acts as an accelerator of capacity building and health system strengthening efforts, creating urgency for the oncologists and their teams be ready to treat their patients. This accomplishes both the long-term systems strengthening and helps our fellow brothers and sisters today; a win-win.

Personally, it is clear in my mind that I need to do better to explain the need, the why, and the how. As my birthday approaches, I hope the unsettled feeling will give rise to renewed clarity to be a voice for the voiceless.

The opportunity is right in front of us, and progress starts whenever we decide. As I donate this birthday to support families who need our help, each $66 gift will directly support a cancer patient and their family. And if each of us get ten of our friends to contribute, we can help more than 1,000 of our fellow human beings have dignity and hope in their cancer journey right now. That would be huge.

Let me ask you, if not now when, if not we, who?

Click here to support

Pat Garcia-Gonzalez is the CEO of The Max Foundation. Under Pat’s direction The Max Foundation is dedicated to accelerating health equity by delivering medication, technology, and services to patients facing cancer and other critical illnesses, focusing our energy on those who no one else is helping. Pat lives in Edmonds, Washington, where she raised her four sons.

Related Articles

  • Spot On CML: Improving CML Diagnostics One Patient at a Time

    Spot On CML: Improving CML Diagnostics One Patient at a Time

    February 21, 2018 · The Max Foundation and Dr. Jerry Radich of the Fred Hutchinson Cancer Research Center are partnering to help tackle the problem of access to accurate tests for chronic myeloid leukemia (CML) diagnostics in low- and middle-income countries through Spot On CML. Spot On CML is a low-cost, paper-based diagnostic testing method for CML, developed by Dr. Radich’s lab at Fred Hutch. Through a Spot On CML test, a physician spots a patient’s blood onto a paper test card and sends it to Dr. Radich’s lab for processing, where they perform accurate diagnostic testing on the samples even after weeks of transport. Once patients are diagnosed, The Max Foundation connects them with available treatments free of charge.

  • The Max Foundation Announces CancerPath to Care to Treat Up to 36,000 People Living with Leukemia, Breast and Certain Rare Cancers in Over 70 Low- and Middle-income Countries by 2025

    The Max Foundation Announces CancerPath to Care to Treat Up to 36,000 People Living with Leukemia, Breast and Certain Rare Cancers in Over 70 Low- and Middle-income Countries by 2025

    New initiative expands existing collaboration with Novartis focused on chronic myeloid leukemia and other rare cancers, to support patient access to care for breast cancer, the leading cause of death in women globally

  • The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

    The Max Foundation (Max) and the International PNH Interest Group (IPIG) Announce Collaboration to Improve Care and Management for People Living with Paroxysmal Nocturnal Hemoglobinuria (PNH) in Low-Resource Countries

    IPIG joins Max’s Humanitarian Partnership for Access to Critical Treatments (Humanitarian PACT) and will provide medical education and training on PNH care and management Max will provide access to innovative treatment as part of the multi-stakeholder collaboration focused on eradicating survival disparities in 53 low-resource countries People living with this rare blood disease require frequent….